P2.06. First-Line Camrelizumab Plus Chemotherapy for Advanced Non-squamous NSCLC with Brain Metastases: Updated Data from CAP-BRAIN - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
xue hou
Meta Tag
Speaker xue hou
Topic Metastatic NSCLC: Immunotherapy - Prospective
Keywords
CAP-BRAIN trial
camrelizumab
chemotherapy
non-squamous non-small cell lung cancer
brain metastases
intracranial objective response rate
intracranial progression-free survival
overall progression-free survival
overall survival rate
treatment-related adverse events
Powered By